To serve life through health. With respect to our patients and customers, our colleagues and investors, our strategic partners and our society.
Win Medica is a pharmaceutical company with high goals, modern strategy and vision. Based on a high scientific background, it aspires to be soon a true partner of the Health institutions.
To serve life through health, with respect for our patients and clients, our colleagues and investors, our strategic partners and our society.
Win Medica has as a priority the upgrade of the patient's care in order to improve his quality of life. The introduction in the Greek Pharmaceutical market, which excel in action and safety in comparison with current treatments, will provide reliable solutions to the therapeutic gap faced by the doctor today, saving valuable resources for patients and health care providers.
Promiste for Health, Promise for Life
Win Medica is a pharmaceutical company, with a modern strategy, that serves the improvement of Health and Quality of Life as well as the Saving of Resources in the health system by approaching its goals through:
Win Medica Quality Policy
Here you can find the Win Medica Quality Policy, revised according to the new ISO 9001: 2015 standard. As well as the Certificate of Quality Management, and the Certificate of Ministerial Decision ΔΥ8Δ / Γ.Π. ΟΙΚ / 1348/2004 on the “Good Practice of Distribution of Medical Devices”.
Corporate Social Responsibility
At Win Medica, corporate responsibility is a fundamental principle that surrounds our entire business and influences our overall attitude towards social and environmental issues. Every activity of the company develops based on our values, vision and mission. We act responsibly and with respect while reciprocating to society.
At Win Medica we consider it important to develop corporate responsibility actions from the first years of our operation. We focus on 3 main areas of action.
Since its establishment in 2008, Win Medica has been a partner of selection of the leading multinational pharmaceutical companies Novartis, Pfizer, Accord Healthcare, Sequris, in the promotion of products of various therapeutic categories, mainly for the treatment of cardiovascular & metabolic diseases.
Win Medica is particularly interested in introducing new therapeutic solutions for patients that will complement the existing portfolio consisting of innovative in-patent products, non-patent original products as well as branded generic products.
Win Medica’s business development division focuses on identifying and evaluating potential collaboration opportunities by creating new growth rates for the company and its potential partners, according to the following business models:
The skills and experience of Win Medica proved to be essential for the establishment of successful and long-term relationships with our partners, ensuring significant expansion of their products in the Greek market through effective accessibility, quality support in regulatory processes and faithful implementation of the Marketing and sales plan in agreement with the Greek and European principles of Ethics.